The BCR-ABL test detects the fusion gene (Philadelphia chromosome) causing CML/Ph+ ALL, using RT-PCR/FISH on blood/marrow to find and quantify it, crucial for diagnosing these cancers, monitoring treatment response (like TKI therapy), checking for minimal residual disease, and assessing prognosis, essentially checking the abnormal gene’s levels to guide therapy